TRexBio Announces Closing of Initial Public Offering
form
View All ->
Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases
Collaboration will combine Zealand Pharma’s expertise in metabolic health with Generate’s proprietary generative AI platform to create multispecific drug candidates with tailored biological functions Generate will receive $30M upfront, up to $35M in early preclinical milestones, and a total of up to nearly $1.2B in milestones, plus tiered royalties for two initial programs, with an option to add a third The agreement will broaden Zealand Pharma’s modality capabilities beyond peptides while exten
Form 8.3 - Brave Bison Group Plc
Downing LLP LEI: 213800G3X76VBG9SB504 13 October 2026 Form 8.3 re. Brave Bison Group Plc PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Downing LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): Client funds managed by Downing LLP (c) Name of offeror/offeree in relation to whose rele
newsCroesus further strengthens its leadership team as it continues to accelerate growth and product innovation
Wealth industry veteran Drew Brown joins Executive Committee as Vice-President and Chief Client Delivery and Transformation Officer MONTRÉAL, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Croesus, a leading Canadian wealth management technology provider, today announced the appointment of Drew Brown to its Executive Committee as Vice-President and Chief Client Delivery and Transformation Officer, as the company continues to invest strategically in the technology and products shaping the next generation of w
announces
View All ->TRexBio Announces Closing of Initial Public Offering
SOUTH SAN FRANCISCO, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- TRex Bio, Inc. (“TRexBio”) (Nasdaq: TRXB), a clinical-stage biotechnology company focused on tissue Treg biology for the discovery and development of immunoregulatory medicines, today announced the closing of its initial public offering of 8,333,334 shares of its common stock at the initial public offering price of $14.00 per share. The aggregate gross proceeds from the offering, before deducting underwriting discounts and commission
Strive Announces Proposed Initial Public Offering of SATS Stock
DALLAS, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (Nasdaq: ASST) (“Strive” or the “Company”) today announced that, subject to market and other conditions, it intends to conduct an initial public offering (the “offering”) registered under the Securities Act of 1933, as amended (the “Securities Act”), of 5,000,000 shares of Strive’s 15.00% Series A Perpetual SATS Preferred Stock, par value $0.001 per share (the “SATS Stock”). Strive intends to use the net proceeds from the offering for genera
newsTenable Announces Closing of New $400M Secured Revolving Credit Facility
COLUMBIA, Md., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Tenable ® Holdings, Inc. (NASDAQ: TENB), the exposure management company , today announced it has entered into a credit agreement (the “Credit Agreement”) that provides for a $400.0 million senior secured revolving credit facility (the “Revolving Facility”). The Revolving Facility, combined with the previously announced convertible note financing in September, completes the refinancing of Tenable’s prior credit agreement consisting of a previously
group
View All ->
Form 8.3 - Brave Bison Group Plc
Downing LLP LEI: 213800G3X76VBG9SB504 13 October 2026 Form 8.3 re. Brave Bison Group Plc PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Downing LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): Client funds managed by Downing LLP (c) Name of offeror/offeree in relation to whose rele
QuickRefund and The Aquilini Investment Group Announce Strategic Partnership
Vancouver’s Aquilini family makes its first investment within the payments sector, backing QuickRefund’s pre-dispute refund platform for high-risk merchants, ISOs and acquirers BOCA RATON, Fla., Oct. 13, 2026 (GLOBE NEWSWIRE) -- The Aquilini Investment Group , the Vancouver family enterprise behind the Vancouver Canucks and Rogers Arena, has entered payments for the first time through a strategic partnership with ZeFund LLC, the company behind the QuickRefund™ platform. The partnership is anchor
newsForm 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: OCTOPUS INVESTMENTS LTD (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree
Business Digest
newsTrasteel Group Announces First Half of 2026 Results Exceed Plan and Are Consistent with Current Projections for FY 2026
newsZenta Group Company Limited Announces Strategic Re Alignment of Business Focus to AI and Data Solutions
newsForm-8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC - 12 10 2026 - (CGWL)
million
View All ->
Condor Announces October 15, 2026 as Expected Closing Date for C$70 Million Financing
THE BASE SHELF PROSPECTUS AND THE SHELF PROSPECTUS SUPPLEMENT ARE ACCESSIBLE ON SEDAR+ NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Condor Energies Inc. (“ Condor ” or the “ Company ”) (TSX: CDR) announces that the closing date of the previously announced best efforts, public offering for gross proceeds of up to C$25,000,000 (the “ Offering ”) and concurrent non-brokered private placement for gross procee
Essex Capital Markets Delivers $73.4 Million in Third-Quarter Closings Across 22 Transactions
Firm placed 20 of 22 loans with banks, led by a $19.6 million River North office-to-residential conversion CHICAGO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Essex Capital Markets, a Chicago-based commercial real estate debt and equity advisory firm, closed 22 transactions totaling $73.4 million in the third quarter of 2026. The transactions encompassed 293 units, ranging from $785,000 to approximately $19.6 million. The largest closing was 226 W. Ontario St., a 70-unit River North office-to-residential
newsHeadCount Pioneering Civic Engagement Campaign Launched on Discord in Partnership with Super League Targeting 5 Million Hard-to-Reach Gen Z Gamers Ahead of 2026 Midterms
Nonpartisan campaign, powered by Super League and Virtual Vote, co-founded by Justin Hochberg, brings HeadCount’s voter engagement work into Discord gaming communities, building upon Virtual Vote’s 2024 initiative on Roblox SANTA MONICA, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the “Company”), a play-first advertising and audience intelligence company, and Virtual Vote, co-founded by Justin W. Hochberg, today announced a nonpartisan civic engagement campaign on Disco
Business Digest
newsOrqa U.S. Awarded $38 Million for U.S. Department of War Drone Dominance Gauntlet II Competition
newsRoze AI Announces Approximately US$14.8 Million (KRW 19.88 Billion) in New Contracts for AI-Powered Fire Risk Forecasting
newsSunrise Realty Trust Announces $20 Million Stock Repurchase Program
global
View All ->
Apex Capital Partners Acquires Peck & Nascimben Global, a Citizenship by Investment Firm Licensed in African Countries
TORONTO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Apex Capital Partners , a boutique advisory firm specializing in Investment Migration for high-net-worth clients, today announced that it has acquired Peck & Nascimben Global, a Zürich-based citizenship and residency firm led by its founder and Managing Partner, Marko Peck, who will assume the role of Vice President at Apex Capital Partners, effective immediately. Peck & Nascimben Global specializes in providing clients with citizenship by investment in
Brazilian Global Workers Lead Latin American Earnings, Averaging $5,329 per month
Among the highest-earning professionals, 82.5% land contracts through referrals or LinkedIn, according to a survey by Higlobe New York, NY, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Latin American professionals working for U.S. clients, earn on average 66% more than if they worked for local companies . This result is primarily driven by Brazil, where average monthly earnings reached $5,329—the highest among the surveyed countries. The data comes from The Global Contractor Insights Report by Higlobe, a U
newsGlobal Gene Transfer Technologies Market to Reach $8.2 Billion by 2031
“According to BCC Research, the global gene transfer technologies market is projected to reach $8.2 billion by 2031, at a CAGR of 11.8% from 2026 to 2031, driven by growing demand for cell and gene therapies, rising chronic and genetic diseases, and advances in gene delivery technologies.” Boston, Oct. 13, 2026 (GLOBE NEWSWIRE) -- The global gene transfer technologies market is projected to grow from $4.2 billion in 2025 to $8.2 billion by 2031, at a compound annual growth rate (CAGR) of 11.8% f
Business Digest
newsTreasure Global Signs MOU to Expand Medical Supply and Pharmaceutical Distribution Across Southeast Asia
newsIntellivisa Raises $3M to Build the Clearance Layer for Global Travel
newsDiginex Shareholders Approve Transformative Resulticks Combination, to Create a Global AI-Powered Enterprise Intelligence Platform
Magazine Focus
The Business of Reinvention: How Companies Adapt to a Changing World
Change has become a permanent part of doing business. Markets shift faster, customer expectations evolve, technology redraws competitive boundaries and established operating models face constant pressure. This edition examines how companies can approach reinvention through smarter processes, digital capability, product thinking and organizational flexibility. It explores why adaptation is no longer a response to crisis, but an ongoing discipline for businesses seeking relevance, resilience and sustainable growth.
Reinvention does not always require abandoning what already works. Often, it begins with understanding what must change, what should remain and where new capabilities can create meaningful value. In this edition, we look at business transformation as a continuous process shaped by technology, customers and changing markets, with an emphasis on practical thinking rather than fashionable disruption.
The day in focus. Delivered to your inbox.
A concise daily briefing of key stories, insights and developments, selected by our editorial team.
By subscribing, you agree to our Privacy Policy. Unsubscribe at any time.